Interestingly, the authors found that simultaneous ICAM-1/VCAM-1 blockade did not further inhibit leukocyte adhesion compared to VCAM-1 blockade alone, implicating VCAM-1 as an optimal adhesion target for selective inhibition of colitis-associated leukocyte recruitment [50]. Here, ICAM1 is linked to colitis.